Among CHD1 target genes, immediate early response 3 (IER3), leukemia inhibitory factor (LIF), and colony stimulating factor 2 (CSF2) were significantly correlated with ESS2 expression in patients with prostate cancer (Fig. 2m). This evidence concerns the gene IER3 and prostate carcinoma.